Pfizer (PFE) earnings Q1 2024
Jakub Porzycki | Nurphoto | Getty Images Pfizer on Wednesday reported first-quarter revenue and adjusted profit that beat expectations and hiked its full-year profit outlook, benefiting from its broad cost-cutting…
Match adds two directors in deal with activist investor
Nurphoto | Nurphoto | Getty Images Tinder and Hinge operator Match Group added two new directors and signed an agreement with Elliott Management, months after the activist investor was reported…
China would block sale of short video app
Visitors are visiting TikTok’s stand at the Appliance & Electronics World Expo (AWE) in Shanghai, China, on April 27, 2023. On March 14, 2024, the United States will pass a…
Trimble announces share buyback, two new directors after Jana stake
The Trimble logo is displayed on a smartphone. Igor Golovniov | SOPA Images | LightRocket | Getty Images Industrial technology company Trimble announced on Tuesday it would buy back up…
Pfizer (PFE) Q3 earnings report 2023
Pfizer on Tuesday reported a narrower-than-expected adjusted loss for the third quarter as the drugmaker recorded charges largely related to struggles for its Covid antiviral treatment Paxlovid and the Covid…
GSK sues Pfizer claiming RSV vaccine patent infringement
Jun Li | Istock | Getty Images GlaxoSmithKline on Wednesday sued Pfizer in U.S. court, alleging patent infringement over Britain-based GSK’s respiratory syncytial virus vaccine. GSK claims New York-based Pfizer’s…
J&J to reduce Kenvue stake by 80% through stock exchange offer
Kenvue, a unit of Johnson & Johnson’s consumer health business. CFOTO | Future Publishing | Getty Images Johnson & Johnson on Monday said it plans to reduce by at least…
J&J investors can soon swap shares for Kenvue stock
Thibaut Mongon, CEO and Paul Ruh CFO of Kenvue Inc. a Johnson & Johnson’s consumer-health business, pose together during the company’s IPO at the New York Stock Exchange (NYSE) in…
Novartis (NVS) earnings report Q2 2023
Novartis shares jumped on Tuesday after the Swiss drugmaker raised its full-year guidance on strong drug sales and announced a $15 billion share buyback. The company made both announcements as…
Pfizer to raise $31 billion for Seagen deal in debt offering
A logo for Pfizer is displayed on a monitor on the floor at the New York Stock Exchange, July 29, 2019. Brendan McDermid | Reuters Pfizer plans to raise $31…